July 9, 2026- Confusion is widespread in the healthcare market as new ADA-related requirements for medical diagnostic equipment approach enforcement deadlines in 2026. In this Repertoire podcast interview, Publisher Scott Adams speaks with Brad Baker, President of MTI. The conversation focuses on what the ADA accessibility requirements actually mean for medical diagnostic … [Read more...]
SMI releases executive briefing on supply chain integration & clinician collaboration
July 7, 2026- A new Executive Briefing, created by the SMI Physician Advisory Group, highlights the ways in which the healthcare supply chain continues to mature, evolving beyond its traditional transactional role to become a strategic partner in both the delivery of patient care and the management of overall costs. Per the executive briefing, the current healthcare environment … [Read more...]
From Trend Fluctuations to Action: The Lab’s Role in Ongoing Drug Surveillance
July 6, 2026- After more than a decade of steady increases driven largely by illicit fentanyl, U.S. overdose deaths have begun to shift – underscoring both progress and continued risk. According to the Centers for Disease Control and Prevention (CDC), overdose deaths climbed sharply from 2013 through 2022, peaking at nearly 110,000 deaths. Synthetic opioids, primarily fentanyl, … [Read more...]
Thermo Fisher Scientific to hold upcoming earnings conference
July 6, 2026- Thermo Fisher Scientific Inc. announced that it will release its financial results for the second quarter 2026 before the market opens on Thursday, July 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on … [Read more...]
U.S. mortality rate hits record low, per the CDC
July 6, 2026- The U.S. death rate fell to a record low in 2025, according to data from the Centers for Disease Control and Prevention (CDC), released last week Thursday. According to the CDC's Vital Statistics Rapid Release report, the death rate in 2025 was 689.2 per 100,000 people in 2025. The top two underlying causes of death in the U.S. were heart … [Read more...]
UPMC launches new nursing pathways for future caregivers
July 6, 2026- The UPMC Jameson School of Nursing at UPMC Hamot in Erie, Pa. is expanding opportunities for future nurses with the launch of two new educational pathways beginning in fall 2026: an advanced placement option for military medics and paramedics that recognizes prior clinical experience and a new 24-month extended nursing program designed for students seeking a more … [Read more...]
Medline expands northern California distribution capacity following fire
July 6, 2026- Medline has announced a lease agreement for an existing 925,000-square-foot warehouse in Tracy, Calif., for immediate occupancy, as well as a 709,000-square-foot facility nearby in Stockton, Calif., for use in January 2027. These two facilities total more than 1.6 million square feet of new medical supplies distribution center space and more than supplant the 1 … [Read more...]
Leveraging Simplicity Within Ambulatory Surgery Centers
July 2, 2026- In a recent episode of the ASC Insights Series podcast hosted by Outcomes Rocket, host Saul Marquez spoke with Blake Tatum, VP of US Commercial for Medtronic Acute Care and Monitoring, and Mike Lessick, VP of Sales and Marketing, Patient Monitoring and Life Support at Mindray North America, about the new partnership between Medtronic and Mindray. This new … [Read more...]
Pfizer declares Q3 2026 dividend
July 2, 2026- Pfizer Inc. announced that its board of directors declared a $0.43 third-quarter 2026 dividend on the company’s common stock, payable September 1, 2026, to holders of the Common Stock of record at the close of business on July 24, 2026. The third-quarter 2026 cash dividend will be the 351st consecutive quarterly dividend paid by Pfizer. Continue Reading … [Read more...]
HCA Healthcare highlights new pediatric research findings
July 2, 2026- HCA Healthcare, Inc. announced new research published in The New England Journal of Medicine (NEJM) demonstrating promising results from a gene-editing therapy being investigated in children ages 5-11 with severe sickle cell disease and transfusion-dependent beta thalassemia. Building on this research, HCA Healthcare’s Sarah Cannon Transplant … [Read more...]









